ArticleHip & pelvis2025
Using Risk Factors and Preoperative Inflammatory Markers to Predict 3-Year Mortality in Patients with Unstable Intertrochanteric Femur Fractures.
Article in Hip & pelvis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Efficacy of Injectable Calcium Composite Bone Substitute Augmentation for Osteoporotic Intertrochanteric Fractures: A Prospective, Non-Randomized Controlled Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Preoperative biomarkers such as the neutrophil‑to‑lymphocyte ratio (NLR), lymphocyte‑to‑C‑reactive protein ratio (LCR), and albumin have been proposed to predict postoperative outcomes in various conditions. This study investigated their association with 3‑year mortality in elderly patients undergoing closed reduction and internal fixation with proximal femoral nail anti‑rotation (CRIF with PFNA) for unstable intertrochanteric femur fractures (UIFF). Materials and Methods: We retrospectively reviewed 306 patients aged ≥65 years who underwent CRIF with PFNA for UIFF between April 2012 and December 2020. Receiver operating characteristic curve analysis determined optimal cutoffs: LCR 0.441 (sensitivity 48.2%, specificity 78.4%), NLR 3.573 (sensitivity 83.2%, specificity 36.3%), and albumin 3.250 g/dL (sensitivity 52.0%, specificity 76.1%). Patients were dichotomized into low versus high groups for each marker. Univariate and multivariate Cox regression analyses assessed associations with 3‑year mortality. Results: At 3 years postoperatively, 76 patients (30.4%) had died. Kaplan-Meier survival analysis revealed that patients with low LCR (<0.441) and low albumin (<3.250 g/dL) had significantly shorter survival compared to those with higher values. In contrast, stratification by NLR did not yield significant differences in survival. Multivariate Cox regression identified both low LCR and low albumin as independent predictors of increased 3‑year mortality ( Conclusion: Preoperative LCR and albumin levels are valuable prognostic biomarkers for 3‑year survival following CRIF with PFNA in elderly UIFF patients. Incorporating these parameters into preoperative risk assessment may improve clinical decision‑making and patient counseling, while NLR appears less predictive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.